Rincon Pharmaceuticals, Inc.eukaryotic algae


turning the corner in biologics...



Setting the industry standard for the development of human therapeutics in eukaryotic algae




Rincon's mission is to dramatically increase the availability and affordability of recombinant protein therapeutics.

Rincon's patented algal protein expression system - AlgRx - enables rapid development and commercialization of complex recombinant proteins. AlgRx provides faster, more efficient, and more scalable protein production than conventional manufacturing and other alternative production platforms.



Latest News



11/29/2007:The World Economic Forum Announces Technology Pioneers 2008: Rincon Pharmaceuticals Selected




World Economic Forum Technology Pioneer 2008








   © 2007 Rincon Pharmaceuticals, Inc.   |    Terms and Conditions   |   Privacy Policy   
eukaryotic algae